Lene Meldgaard Knudsen

2.8k total citations
50 papers, 1.9k citations indexed

About

Lene Meldgaard Knudsen is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Lene Meldgaard Knudsen has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 20 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Lene Meldgaard Knudsen's work include Multiple Myeloma Research and Treatments (28 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Lene Meldgaard Knudsen is often cited by papers focused on Multiple Myeloma Research and Treatments (28 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Lene Meldgaard Knudsen collaborates with scholars based in Denmark, Norway and Sweden. Lene Meldgaard Knudsen's co-authors include Martin Hjorth, Erik Hippe, Hans Erik Johnsen, Peter Gimsing, Thomas Rasmussen, Jan Westin, Erik Holmberg, Inger Marie S. Dahl, Inge Marie Svane and Annette Juul Vangsted and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Lene Meldgaard Knudsen

50 papers receiving 1.8k citations

Peers

Countries citing papers authored by Lene Meldgaard Knudsen

Since Specialization

Citations

This map shows the geographic impact of Lene Meldgaard Knudsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lene Meldgaard Knudsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lene Meldgaard Knudsen more than expected).

Fields of papers citing papers by Lene Meldgaard Knudsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lene Meldgaard Knudsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lene Meldgaard Knudsen. The network helps show where Lene Meldgaard Knudsen may publish in the future.

Co-authorship network of co-authors of Lene Meldgaard Knudsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lene Meldgaard Knudsen. A scholar is included among the top collaborators of Lene Meldgaard Knudsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lene Meldgaard Knudsen. Lene Meldgaard Knudsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial 2020 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Carsten Helleberg, (unknown), (unknown), Shamaila Munir Ahmad, Lars Rønn Olsen, Tobias Wirenfeldt Klausen, (unknown), Morten Hansen, Evelina Martinenaite, Özcan Met, Inge Marie Svane, Lene Meldgaard Knudsen, Mads Hald Andersen	23
2	Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study 2018 ·European Journal of Cancer ·Maja Bech Juul, (unknown), Henriette Engberg, Sonja Wehberg, (unknown), (unknown), Helene Bjørg Kristensen, Joachim Bæch, (unknown), Michael Roost Clausen, Rebecca Valentin, Lene Meldgaard Knudsen, Lars Munksgaard, Tarec Christoffer El‐Galaly, Henrik Frederiksen, Thomas Stauffer Larsen	58
3	Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial 2016 ·PubMed ·(unknown), Shamaila Munir Ahmad, Niels Abildgaard, Per thor Straten, Inge Marie Svane, Mads Hald Andersen, Lene Meldgaard Knudsen	15
4	FDG PET/CT in cancer: comparison of actual use with literature-based recommendations 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Henrik Petersen, Paw Christian Holdgaard, Poul Henning Madsen, Lene Meldgaard Knudsen, (unknown), (unknown), Max Rohde, Christian Godballe, Bodil Elisabeth Engelmann, Karsten Bech, (unknown), Ole Mogensen, Jens Karstoft, Jørgen Johansen, (unknown), Allan Johansen, Poul Flemming Høilund‐Carlsen	41
5	Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study 2012 ·European Journal Of Haematology ·Martin Hjorth, Øyvind Hjertner, Lene Meldgaard Knudsen, Nina Gulbrandsen, Erik Holmberg, Per Trøllund Pedersen, Niels Frost Andersen, Björn Andréasson, Rolf Billström, Kristina Carlson, Margaretha S. Carlsson, Max Flogegård, Karin Forsberg, Peter Gimsing, Torbjörn Karlsson, Olle Linder, Hareth Nahi, (unknown), Agneta Swedin, (unknown)	41
6	Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma 2010 ·Cytometry Part B Clinical Cytometry ·Hans Erik Johnsen, Martin Bøgsted, Tobias Wirenfeldt Klausen, Peter Gimsing, Alexander Schmitz, E Kjærsgaard, (unknown), Pia von Voss, Lene Meldgaard Knudsen, Anne K. Mylin, Johan Lanng Nielsen, Bo Björkstrand, Astrid Gruber, Stig Lenhoff, Kari Remes, Inger Marie S. Dahl, (unknown), Karen Dybkær	19
7	Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma 2010 ·Haematologica ·T. Rasmussen, Jacob Haaber, I. M. Dahl, Lene Meldgaard Knudsen, Gitte Kerndrup, Marianne Lodahl, Hans Erik Johnsen, Michael Kuehl	38
8	A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity 2008 ·Lund University Publications (Lund University) ·Nina Gulbrandsen, Anders Waage, Peter Gimsing, Ingemar Turesson, Gunnar Juliusson, Niels Abildgaard, Bo Björkstrand, Kristina Carlson, I. M. Dahl, Karin Forsberg, Lene Meldgaard Knudsen, Johan Lanng Nielsen, (unknown), Ingerid Nesthus, Maria Strandberg, Finn Wislöff, Peter Fayers	16
9	The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT 2008 ·Bone Marrow Transplantation ·Annette Juul Vangsted, Tobias Wirenfeldt Klausen, (unknown), Peter Gimsing, (unknown), Anne Ortved Gang, Niels Abildgaard, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Hans Gregersen, Ulla Vogel	28
10	Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis 2007 ·British Journal of Haematology ·Jacob Haaber, Niels Abildgaard, Lene Meldgaard Knudsen, Inger Marie S. Dahl, Marianne Lodahl, Mads Thomassen, Gitte Kerndrup, Thomas Rasmussen	38
11	Toll-like receptors mediate proliferation and survival of multiple myeloma cells 2006 ·Leukemia ·Janne Ø. Bohnhorst, T. Rasmussen, Siv Helen Moen, (unknown), Lene Meldgaard Knudsen, Magne Børset, Terje Espevik, Anders Sundan	124
12	Magnetic resonance investigation of bone marrow following priming and stem cell mobilization 2006 ·Journal of Magnetic Resonance Imaging ·Elizaveta Chabanova, Hans Erik Johnsen, Lene Meldgaard Knudsen, Lene Larsen, Vibeke Løgager, (unknown), (unknown)	5
13	Toxicity in standard melphalan–prednisone therapy among myeloma patients with renal failure – a retrospective analysis and recommendations for dose adjustment 2005 ·British Journal of Haematology ·Kristina Carlson, Martin Hjorth, Lene Meldgaard Knudsen, (unknown)	46
14	Molecular and Clinical Follow-Up after Treatment of Multiple Myeloma 2004 ·Acta Haematologica ·Thomas Rasmussen, Lene Meldgaard Knudsen, Tuan Khai Huynh, Hans Erik Johnsen	5
15	C-MAF Oncogene Dysregulation in Multiple Myeloma: Frequency and Biological Relevance 2003 ·Leukemia & lymphoma ·Thomas Rasmussen, Lene Meldgaard Knudsen, Inger Marie S. Dahl, Hans Erik Johnsen	18
16	Accuracy of Duplex Scan of Internal Carotid Arteries 2002 ·European Journal of Vascular and Endovascular Surgery ·Lene Meldgaard Knudsen, Allan Johansen, Per Justesen, (unknown)	6
17	Frequency and prognostic relevance of cyclin D1 dysregulation in multiple myeloma 2001 ·European Journal Of Haematology ·Thomas Rasmussen, Lene Meldgaard Knudsen, Hans Erik Johnsen	18
18	Evaluation of Mobilized CD34+ Cell Counts to Guide Timing and Yield of Large-Scale Collection by Leukapheresis 1998 ·Journal of Hematotherapy ·Lene Meldgaard Knudsen, Eva Gaarsdal, (unknown), (unknown), Hans Erik Johnsen	24
19	Improved Priming for Mobilization of and Optimal Timing for Harvest of Peripheral Blood Stem Cells 1996 ·Journal of Hematotherapy ·Lene Meldgaard Knudsen, Eva Gaarsdal, (unknown), (unknown), (unknown), Hans Erik Johnsen	35
20	Renal function in newly diagnosed multiple myeloma — A demographic study of 1353 patients 1994 ·European Journal Of Haematology ·Lene Meldgaard Knudsen, Erik Hippe, Martin Hjorth, Erik Holmberg, Jan Westin	186

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact